FDA Warns Novartis' MS Drug Carries Risk Of Brain Infection
Novartis AG has reported two cases of a brain infection in patients taking its medication for multiple sclerosis, the U.S. Food and Drug Administration announced Tuesday....To view the full article, register now.
Already a subscriber? Click here to view full article